Cargando…
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies
Chimeric antigen receptor (CAR) T-cell therapy, an emerging immunotherapy, has demonstrated promising clinical results in hematological malignancies including B-cell malignancies. However, accessibility to this transformative medicine is highly limited due to the complex process of manufacturing, li...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for Molecular and Cellular Biology
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125425/ https://www.ncbi.nlm.nih.gov/pubmed/30110720 http://dx.doi.org/10.14348/molcells.2018.0242 |